Delta-Fly Pharma, Inc.
Biopharmaceutical firm developing novel anticancer drugs from existing components.
4598 | T
Overview
Corporate Details
- ISIN(s):
- JP3549370009
- LEI:
- Country:
- Japan
- Address:
- 徳島市川内町宮島錦野３７番地の５
Description
Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer drugs. The company's core strategy is its proprietary "Module Drug Development" concept, an approach that combines existing pharmaceutical components to create novel therapeutic agents. This methodology aims to develop effective cancer treatments with significantly reduced side effects and at reasonable prices, thereby improving the quality of life for patients. The company's pipeline includes several drug candidates for various cancers, with some, such as DFP-10917 for refractory/relapsed acute myeloid leukemia, advancing to late-stage clinical trials. Delta-Fly Pharma focuses on creating gentle yet potent therapies, including nucleoside analogs and RNA therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-30 07:15 |
内部統制報告書－第11期(令和2年4月1日－令和3年3月31日)
|
Japanese | 21.8 KB | ||
| 2021-06-30 07:14 |
有価証券報告書－第11期(令和2年4月1日－令和3年3月31日)
|
Japanese | 889.8 KB | ||
| 2021-02-12 08:19 |
四半期報告書－第11期第3四半期(令和2年10月1日－令和2年12月31日)
|
Japanese | 166.1 KB | ||
| 2020-11-13 03:08 |
四半期報告書－第11期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | 145.7 KB | ||
| 2020-08-14 07:42 |
四半期報告書－第11期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | 115.1 KB | ||
| 2020-06-29 03:34 |
有価証券報告書－第10期(平成31年4月1日－令和2年3月31日)
|
Japanese | 1.2 MB | ||
| 2020-02-14 06:32 |
四半期報告書－第10期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | 116.7 KB | ||
| 2019-11-14 07:09 |
四半期報告書－第10期第2四半期(2019/07/01－2019/09/30)
|
Japanese | 142.5 KB | ||
| 2019-08-14 07:09 |
四半期報告書－第10期第1四半期(2019/04/01－2019/06/30)
|
Japanese | 111.3 KB | ||
| 2019-06-24 06:15 |
有価証券報告書－第9期(平成30年4月1日－平成31年3月31日)
|
Japanese | 1.2 MB | ||
| 2019-02-14 02:30 |
四半期報告書－第9期第3四半期(2018/10/01－2018/12/31)
|
Japanese | 113.8 KB | ||
| 2018-11-14 03:31 |
四半期報告書－第9期第2四半期(2018/07/01－2018/09/30)
|
Japanese | 138.8 KB |
Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Delta-Fly Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
